pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
retifanlimab
Zynyz (retifanlimab-dlwr)
Squamous Non-Small Cell Lung Cancer
$INCY
INCYTE CORP
6 cat
pre_registration
durvalumab
Imfinzi (durvalumab)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$AZN
ASTRAZENECA PLC
2 cat
unani medicine
no indication
Central Council for Research in Unani Medicine
2 cat
← prev
page 8 of 231
next →
Pain
89
Neurology
1
undisclosed chemotherapy
no indication
National Cancer Institute US
2 cat
Marketed
(insulin aspart + insulin aspart protamine)
Insulin Aspart + Insulin Aspart Protamine Novo ((insulin aspart + insulin aspart protamine))
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
1 cat
AG-181
no indication
$AGIO
AGIOS PHARMACEUTICALS, INC.
1 cat
AL-1211
no indication
AceLink Therapeutics Inc
1 cat
Alii Supplement
no indication
Texas Christian University
1 cat
BI-765179
no indication
Boehringer Ingelheim International GmbH
1 cat
CT-0594CP CAR-T Cells
no indication
CARsgen Therapeutics Holdings Ltd
1 cat
HH-006
no indication
Huahui Health Ltd
1 cat
Marketed
Jelmyto
Jelmyto (mitomycin)
Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
$URGN
UroGen Pharma Ltd.
1 cat
KK-4277
no indication
Kyowa Kirin Co Ltd
1 cat
N-acetylcysteine
no indication
Massachusetts Eye and Ear Infirmary
1 cat
NN-7442
no indication
Altasciences Co Inc
1 cat
RSN-0402
no indication
Shenzhen Resproly Biopharmaceutical Co Ltd
1 cat
TQH-2722
no indication
Chia Tai Tianqing Pharmaceutical Group Co Ltd
1 cat
[177Lu]Lu-PSMA-597
no indication
St. Vincent Health System
1 cat
adenovirus vector (spike protein) vaccine
no indication
$OCGN
Ocugen, Inc.
1 cat
Phase 3
asundexian
asundexian
Ischemic Stroke
Bayer AG
1 cat
autologous mitochondria
no indication
University of Washington
1 cat
Marketed
danazol
Danazol
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
Lannett Co Inc
1 cat
Marketed
diclofenac ER
Licart (diclofenac)
Pain
IBSA Pharma Inc
1 cat
Marketed
dinoprostone ER
Cervidil (dinoprostone)
Cervical Ripening In Pregnant Women Near Term
Ferring Pharmaceuticals Inc
1 cat
melatonin ER
no indication
Faculty of Medicine Chulalongkorn University
1 cat
nefopam
no indication
Buddhachinaraj Hospital
1 cat
Marketed
nicotine
Nicorette (nicotine [USP])
Smoking Cessation
NAL Pharmaceuticals Ltd
1 cat
norfloxacin
no indication
Yunpeng Pharmaceutical Co Ltd
1 cat
phenylephrine
no indication
Sawai Man Singh Medical College
1 cat
Phase 2
siplizumab
Vicalex (siplizumab)
Transplant Rejection
ITB-Med AB
1 cat
